Virtudes CEO, Jamiel Jamieson, sees the potential of helping thousands of people recover faster from COVID-19 if there is a targeted approach to developing CDB treatments as part of patient care. He believes that the plant could help stem the tide of long recovery periods and severe symptoms for COVID-19 patients.